Home › Kanser sa Prostate › Iowa › Cedar Rapids
Pag-aaral pangklinika para sa Kanser sa Prostate sa Cedar Rapids, IA
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cedar Rapids. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Nagre-recruitPhase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Nagre-recruitPhase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi ang layo
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi ang layo
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Nagre-recruitPhase 3
- Univ Of Iowa Hospitals And Clinics, Iowa City · 25 mi ang layo
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Nagre-recruitPhase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Nagre-recruitPhase 1
- University of Iowa Health Care, Iowa City · 25 mi ang layo
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Nagre-recruitPhase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Iowa City · 25 mi ang layo
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi ang layo
Preop Laxatives in Robotic Urologic Surgery
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
- University of Iowa Hospitals & Clinics, Iowa City · 25 mi ang layo
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN42 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Cedar Rapids
- Non-Small Cell Lung Cancer20 pag-aaral
- Kanser sa Suso17 pag-aaral
- Acute Myeloid Leukemia16 pag-aaral
- Kanser (lahat ng uri)15 pag-aaral
- Multiple Myeloma15 pag-aaral
- Kanser sa Baga14 pag-aaral
- Colorectal Cancer13 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg12 pag-aaral
- Melanoma10 pag-aaral
- Stroke10 pag-aaral
- Metastatic Cancer9 pag-aaral
- Kanser ng Endometrium9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.